Calculation and evaluation of the vital head organs dose during Neutron Therapy in Tehran Research Reactor using Zubal phantom

Authors

10.22052/7.3.13

Abstract

In the recent years some studies has been done to consider the capability of Tehran Research Reactor for Boron neutron capture therapy (BNCT). The purpose of this study is to evaluate the sensitive organs dose during the treatment of patient with deep brain tumor by TRR. The calculation has been carried out using the Monte Carlo code MCNPX for ZUBAL head and neck phantom. The method was tested for 3 different boron concentration injected to patient located in TRR thermal column from human head. The total dose (Dw) was defined as the sum of physical dose components (Di) multiplied by weighting factors (wi) of each dose component in a tissue. The MCNP simulations were carried out with the MCNPX version of 2.6. In order to calculate the dose absorption, the tally F4 was used. For the dose conversion, pointwise KERMA factors from ICRU-46 were directly input with DE and DF cards.
Treatment time based on absorbing 20 Gy-Eq by tumor approximately from 15 to 30 minutes changes for all trials. The results indicate that increasing boron concentration causes decreasing lens and thyroid dose received. In all trials parietal lobes receive the most dese rather than other parts. It was found that fast neutron dose component has most contribution in skin and lenses doses. But for the thyroid gamma dose component has most contribution. It is considered that side-irradiation would not be safe treatment for vital organs and take long time.

Keywords


[1] W.A.G. Sauerwein, A. Wittig, R. Moss, Y. (Eds.) Nakagawa. Neutron capture therapy: principles and applications. Springer :Science & Business Media (2012). [2] Y. Kasesaz, H. Khalafi and F. Rahmani. Design of an epithermal neutron beam for BNCT in thermal column of Tehran research reactor. Annals of Nuclear Energy. 68 (2014) 234–238. [3] Y. Kasesaz, H. Khalafi, F. Rahmani, A. Ezati, M. Keyvani, A. Hossnirokh, M.A. Shamami and M. Monshizadeh. A feasibility study of the Tehran research reactor as a neutron source for BNCT. Appl. Radiat. Isot. 90 (2014) 132–137. [4] Y. Kasesaz, H. Khalafi, F. Rahmani, A. Ezzati, M. Keyvani, A. Hossnirokh, M.A. Shamami and S. Amini. Design and construction of a thermal neutron beam for BNCT at Tehran Research Reactor. Appl. Radiat. Isot. 94 (2014) 149–151. [5] J.F. Evans, T.E. Blue and N. Gupta. Absorbed dose estimates to structures of the brain and head using a high‐resolution voxel‐based head phantom. Medical physics, 28(5) (2001) 780–786. [6] H. Jarahi, Y. Kasesaz and S.M. Saleh-Koutahi. Evaluation of the effective dose during BNCT at TRR thermal column epithermal facility. Appl. Radiat. Isot. 110 (2016) 134–137. [7] J.N. Wang, K.W. Lee and S.H. Jiang. Effective dose evaluation for BNCT brain tumor treatment based on voxel phantoms. Appl. Radiat. Isot. 88 (2014) 55–58. [8] M. Monshizadeh, Y. Kasesaz, H. Khalafi and S. Hamidi. MCNP design of thermal and epithermal neutron beam for BNCT at the Isfahan MNSR. Progress in Nuclear Energy, 83 (2015) 427–432. [9] F. Rahmani and M. Shahriari. Dose calculation and in-phantom measurement in BNCT using response matrix method. Appl. Radia. Isot. 69(12) (2011) 1874–1877. [10] H. Fankhauser and P.R. Gavin. Summing up: Clinical papers, in Advances in Neutron Capture Therapy. Springer. (1993) 799–805.